Cancer is a famously complex disease. Despite sharing the ‘cancer’ label, different cancer types can be as structurally and functionally diverse as the tissues from which they arise—physicians and ...
ctDNA testing effectively stratifies Merkel cell carcinoma patients into high and low recurrence risk categories, influencing surveillance strategies. The study's cohorts revealed significant ...
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...
Incidence is increasing faster than melanoma, with typical presentation in the mid-70s and risk amplified by UV exposure, fair skin, immunosuppression, and MCPyV-associated oncogenesis. Accurate ...
Merkel cell carcinoma (MCC) is an aggressive skin cancer with a 40% recurrence rate, lacking effective prognostic biomarkers and surveillance methods. This prospective, multicenter, observational ...
Megha Padi, PhD, is a member of the University of Arizona Cancer Center and an assistant professor at the U of A College of Science. Merkel cell carcinoma is a rare but fast-growing neuroendocrine ...
Merkel cell polyomavirus is one of seven viruses known to cause cancer in humans. Infection with this virus is asymptomatic, but, rarely, it can lead to the development of Merkel cell carcinoma (MCC), ...
BIRMINGHAM, Ala. – Transduction is the changing of one form of energy into another, such as a spoken voice changed into radio waves by a cellphone. Ten years ago, three research teams published a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results